BHCM
TDAC

Brevan Howard Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Brevan Howard Capital Management’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$648K Buy
+60,533
New +$647K ﹤0.01% 1310

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Brevan Howard Capital Management's TDAC Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Translational Development Acquisition Corp (TDAC) in Q2 2026: 60,533 shares worth $648K. The stake represents ﹤0.01% of the portfolio and ranks #1310 among its holdings.

35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Brevan Howard Capital Management held 60,533 shares of Translational Development Acquisition Corp worth $648K as of Q2 2026.
  • Translational Development Acquisition Corp was a new Brevan Howard Capital Management position in Q2 2026.
  • Translational Development Acquisition Corp made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1310 holding.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.